CAP Member Adam Booth, MD, FCAP, discusses iron therapy. “A biomarker test could look for genetic mutations or inflammatory markers linked to iron overload and cancer risk,” said Dr. Booth.
For the full article click here: Precision medicine and iron therapy: The future of supplementation?